Blog
RSS FeedPosted by Michael Wonder on 07 Nov 2019
Statement on the agency’s efforts to protect patients through post-market drug safety surveillance practices
6 November 2019 - Public health and safety is the highest priority at the U.S. FDA. ...
Posted by Michael Wonder on 30 Sep 2019
PHARMAC's reduced funding for epilepsy drug raises concerns over driving, seizures
30 September 2019 - PHARMAC will stop funding two brands of a particular epilepsy drug from Tuesday, meaning patients have ...
Posted by Michael Wonder on 13 Sep 2019
Taranaki man fearful drug funding change will bring back a life of seizures
13 September 2019 - For three years now a normal life has cost Nick Coulton $10 every three months. From ...
Posted by Michael Wonder on 26 Aug 2019
China revises law to ensure drug safety
26 August 2019 - China's top legislature on Monday voted to adopt the revision to the drug administration law as ...
Posted by Michael Wonder on 30 Jul 2019
FDA requires box warnings for Pfizer drug Xeljanz
26 July 2019 - Patients taking 10 mg dose twice a day could experience a higher risk of blood clots or ...
Posted by Michael Wonder on 29 Jul 2019
Harms from uninformative clinical trials
25 July 2019 - Individuals who enroll in clinical trials do so with the belief that their participation will help ...
Posted by Michael Wonder on 11 Jul 2019
Ensuring patient safety and drug manufacturing quality through partnership with European Union regulators
11 July 2019 - The Mutual Recognition Agreement with the European Union allows FDA to more effectively deploy our inspectional resources ...
Posted by Michael Wonder on 23 Jun 2019
Statement on agency’s efforts to increase transparency in medical device reporting
21 June 2019 - In the spirit of promoting public transparency, the U.S. Food and Drug Administration’s Center for Devices ...
Posted by Michael Wonder on 23 Jun 2019
Epilepsy medicine worry
24 June 2019 - A controversial change of epilepsy drug funding could see her and thousands of other people with ...
Posted by Michael Wonder on 29 May 2019
Health advocate says FDA must walk a 'fine line' to ensure affordable drugs are safe
29 May 2019 - Public health advocate Dinesh Thakur said in an interview that aired Wednesday that the FDA is ...
Posted by Michael Wonder on 23 May 2019
B.C. eye doctors warn province of spike in glaucoma cases linked to injections of eye drug
23 May 2019 - Thousands of retinal-disease patients in British Columbia are being exposed to an “increased risk of severe ...
Posted by Michael Wonder on 20 May 2019
FDA's strengthened global inspection program helps ensure generic drug safety
17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines. ...
Posted by Michael Wonder on 13 May 2019
Japan health ministry orders Ono Pharmaceutical to add warning to Opdivo cancer drug after death
10 May 2019 - The health ministry said Thursday that a patient taking the cancer drug Opdivo has died and ...
Posted by Michael Wonder on 10 May 2019
Allegations of widespread fraud raise questions about the safety of generic drugs made overseas
10 May 2019 - It is something we've all heard before: generic drugs are the same as brand-name drugs. They ...
Posted by Michael Wonder on 07 May 2019
Working together for safe medicines in the EU
6 May 2019 - EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines ...